Doravirine (Pifeltro®) is accepted for use within NHSScotland.

Accepted for treatment in combination with other antiretroviral medicinal products, for the treatment of adults infected with HIV-1 without past or present evidence of resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class.

Source:

Scottish Medicines Consortium